Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Natarajan Sethuraman Insider Profile
4 Followers
Natarajan Sethuraman, CSO at Entrada Therapeutics Inc, holds 183.82K shares in Entrada Therapeutics Inc (Ticker: TRDA).
Natarajan Sethuraman has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Natarajan Sethuraman's holdings
Insider Roles
CSO
Roles that Natarajan Sethuraman holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Natarajan Sethuraman
Natarajan Sethuraman's Trading History
List of latest transactions for each holding click on a transaction to see Natarajan Sethuraman's performance on stock
You May Also Like
Natarajan Sethuraman insider profile FAQ
What is the percentage of profitable transactions made by Natarajan Sethuraman?
The percentage of profitable transactions made by Natarajan Sethuraman is ―.
What is the average return per transaction made by Natarajan Sethuraman?
The average return per transaction made by Natarajan Sethuraman is ―.
What stocks does Natarajan Sethuraman hold?
Natarajan Sethuraman holds: TRDA stocks.
What was Natarajan Sethuraman’s latest transaction?
Natarajan Sethuraman latest transaction was an Uninformative Sell of $48.98K.
What was Natarajan Sethuraman's most profitable transaction?
Natarajan Sethuraman’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Natarajan Sethuraman's role in Entrada Therapeutics Inc?
Natarajan Sethuraman's role in Entrada Therapeutics Inc is CSO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.